Dominant negative ATP5F1A variants disrupt oxidative phosphorylation causing neurological disorders
Open Access
- 26 August 2025
- journal article
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 17 (10) , 2562-2585
Abstract
ATP5F1A encodes the α-subunit of complex V of the respiratory chain, which is responsible for mitochondrial ATP synthesis. We describe 6 probands with heterozygous de novo missense ATP5F1A variants that presented with developmental delay, intellectual disability, and movement disorders. All variants were located at the contact points between the α- and β-subunits. Functional studies in C. elegans revealed that the variants were damaging via a dominant negative genetic mechanism. Biochemical and proteomics studies of proband-derived cells showed a marked reduction in complex V abundance and activity. Mitochondrial physiology studies revealed increased oxygen consumption, yet decreased mitochondrial membrane potential and ATP levels indicative of uncoupled oxidative phosphorylation as a pathophysiologic mechanism. Our findings contrast with the previously reported ATP5F1A variant, p.Arg207His, indicating a different pathological mechanism. This study expands the phenotypic and genotypic spectrum of ATP5F1A -associated conditions and highlights how functional studies can provide an understanding of the genetic, molecular, and cellular mechanisms of ATP5F1A variants of uncertain significance. With 12 heterozygous individuals now reported, ATP5F1A is the most frequent nuclear genome cause of complex V deficiency.Keywords
All Related Versions
Funding Information
- Center for Rare and Undiagnosed Genetic Diseases
- National Institutes of Health (U54NS108251)
- National Institutes of Health (U54NS078059)
- Australian National Medical Research Council (2009732)
- Medical Research Future Fund Genomics Health Futures Mission (2016030)
- National Health and Medical Research Council Investigator Grant (2009982)
- National Health and Medical Research Council Investigator Grant (2009982)
- National Human Genome Research Institute (U01HG007709)
- National Human Genome Research Institute (U01HG007942)
- National Institute of General Medical Sciences (GM100756)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50 HD103555)
- Office of Rare Diseases Research (ORDR), NCATS
- NIH/NCCR (S10 OD028538-01A1)
- Royal Children's Hospital Foundation (2019-1198 and 2023-1484)
- The Andrew and Geraldine Buxton Foundation
- Pierce Armstrong Foundation
- Victorian Government's Operational Infrastructure Support Program
- Mito Foundation
- Clinical Translational Core (CTC) of Baylor College of Medicine
- Murdoch Children's Research Institute
- Paula Fox
This publication has 77 references indexed in Scilit:
- Mutant residues suppressing ρ0-lethality in Kluyveromyces lactis occur at contact sites between subunits of F1-ATPaseBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 2000
- The Protein Data BankNucleic Acids Research, 2000
- Parental mosaicism and autosomal dominant mutations causing structural abnormalities of collagen I are frequent in families with osteogenesis imperfecta type III/IVActa Paediatrica, 1997
- THE ATP SYNTHASE—A SPLENDID MOLECULAR MACHINEAnnual Review of Biochemistry, 1997
- The Mitochondrial Genome Integrity Gene, MGI1, of Kluyveromyces lactis Encodes the β-Subunit of F1-ATPaseGenetics, 1996
- Specific mutations in alpha‐ and gamma‐subunits of F1‐ATPase affect mitochondrial genome integrity in the petite‐negative yeast Kluyveromyces lactis.The EMBO Journal, 1995
- Structure at 2.8 Â resolution of F1-ATPase from bovine heart mitochondriaNature, 1994
- Biochemical and molecular investigations in respiratory chain deficienciesClinica Chimica Acta, 1994
- Myosin heavy-chain mutations that disrupt Caenorhabditis elegans thick filament assembly.Genes & Development, 1988
- Mutation in a testis-specific β-tubulin in Drosophila: Analysis of its effects on meiosis and map location of the geneCell, 1980